Schlagwörter
Adalimumab/therapeutic use
3
Adult
3
Aged
3
Belgium
3
Crohn Disease/drug therapy
Crohn's disease
3
Female
3
Gastroenterology & hepatology
3
Gastroentérologie & hépatologie
3
Gastrointestinal Agents/therapeutic use
3
Human health sciences
3
Humans
3
Infliximab/therapeutic use
3
Male
3
Middle Aged
3
Prospective Studies
3
Sciences de la santé humaine
3
Treatment Outcome
3
adalimumab
3
infliximab
3
switching
3